Biden Administration’s Access Model Offers Hope For Cell And Gene TherapiesBy Press Room7 December 2024 In the cell and gene therapy space, science continues to outpace commercialization. Take, for example, the first two sickle cell…
Vertex Is Writing A New Playbook For Pharma R&D. And It’s Working.By Press Room14 May 2024 Vertex Pharmaceuticals (NDAQ: VRTX) stands today as a top 20 pharma company with over a $100 billion market cap. But…